misleading statements

Law firm sues Richtech Robotics for securities fraud over false Microsoft partnership claims made January 27-29, 2026. Investors can apply as lead plaintiffs by April 3.

Portnoy Law Firm files class action against $IT on behalf of investors, alleging false statements about contract value growth and consulting revenue amid massive stock declines.

Class action lawsuit filed against Gartner for allegedly misrepresenting contract value growth and consulting revenue while downplaying economic risks. Stock fell 27% in August 2025, then 21% in February 2026.

Class action lawsuit filed against Corcept Therapeutics alleges material misstatements about relacorilant drug trials and regulatory approval prospects, covering investors from October 2024 through December 2025.

FBRT shareholders pursue class action lawsuit following 14.2% stock plunge tied to dividend reset, over-distribution revelations, and earnings declines.

Mereo BioPharma faces class action lawsuit alleging false statements about failed Phase 3 trials ORBIT and COSMIC. Investors from June 2023-December 2025 eligible; lead plaintiff deadline April 2026.

Class action filed against $METC alleging executives made false statements about Brook Mine development progress. Investors who purchased securities July-October 2025 may be eligible.

Rosen Law Firm files class action against $EOSE for alleged false statements on production capacity and guidance. Lead plaintiff deadline: May 5, 2026.

Securities lawsuit filed against $BRBR over alleged misleading statements on sales growth and competitive positioning. Stock declined after corrective disclosures; lead plaintiff applications due March 23, 2026.

Law Offices of Howard G. Smith launches fraud lawsuits against $SDM, $BRBR, $METC, and $CLEUF, alleging market manipulation, misrepresentation, and pump-and-dump schemes.

Class action lawsuit filed against $REGENXBIO alleging false statements on RGX-111 gene therapy. Covers investors from February 2022 to January 2026.

Securities class action filed against $RARE for allegedly misrepresenting setrusumab efficacy data. Investors may claim damages; lead plaintiff deadline April 6, 2026.

Rosen Law Firm files securities class action against Inovio Pharmaceuticals ($INO) alleging misleading statements on manufacturing deficiencies and overstated regulatory prospects. Lead plaintiff deadline April 7, 2026.

Hagens Berman investigates $BRBR for securities fraud, alleging inflated 2025 sales were driven by retailer inventory hoarding, not consumer demand. Stock crashed 33% after destocking.

Rosen Law Firm urges PomDoctor Ltd. investors to join securities class action before April 7, 2026 deadline. Allegations include false statements, insider dumping, and artificial trading schemes.

Class action lawsuit filed against $PLUG alleging false statements about DOE funding and hydrogen facilities between January-November 2025. Investors have until April 3, 2026 to join.

Rosen Law Firm alerts $METC investors of securities class action lawsuit alleging false statements about mining operations. Class certification deadline set for March 31, 2026.

Snowflake faces securities class action alleging failure to disclose how product efficiency improvements would materially harm consumption-based revenue model.

Securities lawsuit alleges $BBWI made false statements about business strategy and financial guidance. Investors have until March 16, 2026 deadline to join litigation.

Securities class action filed against VTGN alleges misleading statements about fasedienol drug and PALISADE-3 trial. Investors must act by March 16, 2026 deadline.